Ignite Creation Date:
2024-05-06 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 12:47 PM
Study NCT ID:
NCT03547791
Status:
COMPLETED
Last Update Posted:
2019-04-25
First Post:
2018-03-29
Brief Title:
Effects of ACS in Twin With LPB Study Protocol for a RCT
Sponsor:
Seoul National University Hospital
Organization:
Seoul National University Hospital
Study Overview
Official Title:
Effects of Antenatal Corticosteroid in Twin Neonates With Late Preterm Birth Study Protocol for a Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2024-07
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will be the first study that evaluates the effectiveness of antenatal corticosteroid ACS in late preterm twin neonates
Detailed Description:
Antenatal corticosteroid ACS has been proven to prevent adverse outcomes including respiratory morbidities in preterm neonates before 34 weeks of gestations Recently it has been suggested that ACS may be also effective for reduction of respiratory complications in singleton late preterm pregnancies On the contrary there is a paucity of information regarding the effectiveness of ACS in twin neonates with late preterm birth and nowadays guidelines are recommending the use of ACS in twin pregnancies based on the evidences in singleton pregnancies However the effect of ACS in twin needs to be determined because the rate of neonatal morbidities in twin preterm neonates seems to be different from that in singleton neonates This study aims to determine the effectiveness of ACS in late preterm twin neonates
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None